StonvexLoading…
StonvexStonvexStonvexCore line items from DOLE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.17B | $8.48B | $8.25B | $8.02B |
Operating Income | $222.97M | $280.56M | $272.16M | $175.26M |
Net Income | $51.32M | $125.51M | $124.06M | $86.50M |
EPS (Diluted) | $0.53 | $1.32 | $1.30 | $0.91 |
Total Assets | $4.40B | $4.45B | $4.56B | $4.59B |
Total Liabilities | $2.89B | $3.01B | $3.14B | $3.27B |
Cash & Equivalents | $267.85M | $330.02M | $275.58M | $228.84M |
Free Cash Flow OCF − CapEx | $1.71M | $180.29M | $220.56M | $153.33M |
Shares Outstanding | 95.16M | 95.04M | 94.93M | 94.90M |